A.T.S. Pharmaceuticals, a Division of Auriga Laboratories, Inc., Launches Breze(TM) Pads for the Topical Treatment of Acne Vulgaris

CAMARILLO, CA--(Marketwire - April 01, 2008) - Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company today announced the launch of Breze™ Pads (benzoyl peroxide 4.75% and 7.75%). Breze™ Pads complement the current A.T.S. portfolio which also includes Zytopic™ (triamcinolone acetonide, 0.1%), Coraz™ (hydrocortisone lotion USP, 2%), and the Xyralid™ (lidocaine HCl /hydrocortisone acetate) brand.

MORE ON THIS TOPIC